Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

ClinicalTrials.gov ID: NCT00141336

Public ClinicalTrials.gov record NCT00141336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 1:10 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

Study identification

NCT ID
NCT00141336
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
750 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1999 (Type not available)
Primary completion
Not listed
Completion
Jul 2005 (Type not available)
Last update posted
Jan 1, 2007

1999 – 2005

United States locations

U.S. sites
97
U.S. states
31
U.S. cities
74
Facility City State ZIP Site status
Pfizer Investigational Site Phoenix Arizona 85013 —
Pfizer Investigational Site Tucson Arizona 85724 —
Pfizer Investigational Site Bakersfield California 93301 —
Pfizer Investigational Site Berkeley California 94705 —
Pfizer Investigational Site Concord California 94520 —
Pfizer Investigational Site Covina California 91723 —
Pfizer Investigational Site El Cajon California 92021 —
Pfizer Investigational Site Encino California 91436 —
Pfizer Investigational Site La Mesa California 91942 —
Pfizer Investigational Site Marina Del Ray California 90292 —
Pfizer Investigational Site Martinez California 94553 —
Pfizer Investigational Site Northridge California 91325 —
Pfizer Investigational Site Pinole California 94564 —
Pfizer Investigational Site Redondo Beach California 90277 —
Pfizer Investigational Site Sacramento California 95816 —
Pfizer Investigational Site Sacramento California 95823 —
Pfizer Investigational Site San Diego California 92120 —
Pfizer Investigational Site Santa Monica California 90404 —
Pfizer Investigational Site Walnut Creek California 94598 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Englewood Colorado 80110 —
Pfizer Investigational Site Danbury Connecticut 06810 —
Pfizer Investigational Site Miami Florida 33173 —
Pfizer Investigational Site Miami Florida 33176 —
Pfizer Investigational Site Orlando Florida 32806 —
Pfizer Investigational Site Tampa Florida 33609 —
Pfizer Investigational Site Atlanta Georgia 30322 —
Pfizer Investigational Site Chicago Illinois 60611 —
Pfizer Investigational Site Chicago Illinois 60612 —
Pfizer Investigational Site Chicago Illinois 60640 —
Pfizer Investigational Site Crestview Hills Kentucky 41017 —
Pfizer Investigational Site Louisville Kentucky 40202 —
Pfizer Investigational Site Ruston Louisiana 71270 —
Pfizer Investigational Site Baltimore Maryland 21287 —
Pfizer Investigational Site Detroit Michigan 48202-2689 —
Pfizer Investigational Site Golden Valley Minnesota 55422 —
Pfizer Investigational Site Minneapolis Minnesota 55422 —
Pfizer Investigational Site Jackson Mississippi 39216 —
Pfizer Investigational Site St Louis Missouri 63110 —
Pfizer Investigational Site Las Vegas Nevada 89102 —
Pfizer Investigational Site Las Vegas Nevada 89106 —
Pfizer Investigational Site Concord New Hampshire 03301 —
Pfizer Investigational Site Dover New Hampshire 03820 —
Pfizer Investigational Site New Brunswick New Jersey 08901 —
Pfizer Investigational Site New Brunswick New Jersey 08903 —
Pfizer Investigational Site Ridgewood New Jersey 07450 —
Pfizer Investigational Site Albuquerque New Mexico 87131-5021 —
Pfizer Investigational Site Albuquerque New Mexico 87131-5281 —
Pfizer Investigational Site Albuquerque New Mexico 87131 —
Pfizer Investigational Site Brooklyn New York 11203 —
Pfizer Investigational Site New York New York 10021 —
Pfizer Investigational Site The Bronx New York 10467 —
Pfizer Investigational Site Asheville North Carolina 28803 —
Pfizer Investigational Site Asheville North Carolina 28806 —
Pfizer Investigational Site Raleigh North Carolina 27607 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Winston-Salem North Carolina 37103 —
Pfizer Investigational Site Cincinnati Ohio 45219 —
Pfizer Investigational Site Cincinnati Ohio 45242 —
Pfizer Investigational Site Columbus Ohio 43210 —
Pfizer Investigational Site Oklahoma City Oklahoma 73104-5068 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Portland Oregon 97201 —
Pfizer Investigational Site Portland Oregon 97209 —
Pfizer Investigational Site Portland Oregon 97210 —
Pfizer Investigational Site Philadelphia Pennsylvania 19104 —
Pfizer Investigational Site Philadelphia Pennsylvania 19107 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15212 —
Pfizer Investigational Site Ridley Park Pennsylvania 19078 —
Pfizer Investigational Site Upland Pennsylvania 19013 —
Pfizer Investigational Site Cranston Rhode Island 02920 —
Pfizer Investigational Site Knoxville Tennessee 37916 —
Pfizer Investigational Site Memphis Tennessee 38103 —
Pfizer Investigational Site Dallas Texas 75216 —
Pfizer Investigational Site Dallas Texas 75230 —
Pfizer Investigational Site Dallas Texas 75243 —
Pfizer Investigational Site Fort Worth Texas 76107-2699 —
Pfizer Investigational Site Fort Worth Texas 76107 —
Pfizer Investigational Site Houston Texas 77002 —
Pfizer Investigational Site Houston Texas 77025 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Lubbock Texas 79410 —
Pfizer Investigational Site San Antonio Texas 78207 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Alexandria Virginia 22304 —
Pfizer Investigational Site Alexandria Virginia 22311 —
Pfizer Investigational Site Charlottesville Virginia 22908 —
Pfizer Investigational Site Roanoke Virginia 24014 —
Pfizer Investigational Site Roanoke Virginia 24016 —
Pfizer Investigational Site Sterling Virginia 20165 —
Pfizer Investigational Site Bellevue Washington 98004 —
Pfizer Investigational Site Friday Harbor Washington 98004 —
Pfizer Investigational Site Spokane Washington 99202 —
Pfizer Investigational Site Spokane Washington 99204 —
Pfizer Investigational Site Morgantown West Virginia 26507 —
Pfizer Investigational Site Marshfield Wisconsin 54449 —
Pfizer Investigational Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00141336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2007 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00141336 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →